In this study, we want to learn whether more or less treatment for men with intermediate risk prostate cancer is better than the standard of care based on genetics testing results.
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Gregg Goldin
Radiation Oncology - Rex
Clinical or Medical
Interventional
Cancer (Prostate)
23-2932
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
